Detection of SARS-CoV-2 antibodies after confirmed Omicron BA.1 and presumed BA.4/5 infections using Abbott ARCHITECT and Panbio assays

被引:1
作者
Boler, Michael [1 ]
Anderson, Mark [2 ]
Rodgers, Mary [2 ]
Parumoottil, Jessica [1 ]
Olivo, Ana [2 ]
Harris, Barbara [2 ]
Stec, Michael [2 ]
Gosha, Amy [1 ]
Behun, Dylan [1 ]
Holzmayer, Vera [2 ]
Anderson, Abby [2 ]
Greenholt, Ella [2 ]
Fortney, Tiffany [2 ]
Almaraz, Eduardo [2 ]
Cloherty, Gavin [2 ]
Landay, Alan [1 ]
Moy, James [1 ]
机构
[1] Rush Univ, Med Ctr, Dept Anesthesiol, 1725 Harrison St Suite 739, Chicago, IL 60612 USA
[2] Abbott Labs, 100 Abbott Pk Rd, Abbott Pk, IL 60064 USA
来源
IJID REGIONS | 2023年 / 7卷
关键词
SARS-CoV-2; Antibody; Omicron; Nucleocapsid; Spike; Vaccine;
D O I
10.1016/j.ijregi.2023.04.014
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Commercial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody tests were developed before variants with spike protein mutations emerged, leading to concerns that these tests have reduced sensitivity for detecting antibody responses in individuals infected with Omicron subvariants. This study was performed to evaluate Abbott ARCHITECT serologic assays, AdviseDx SARS-CoV-2 IgG II, and SARS-CoV-2 IgG for the detection of spike (S) and nucleocapsid (N) IgG antibody increases in vaccinated healthcare workers infected with Omicron subvariants.Methods: During the BA.1/2 and BA.4/5 waves, 171 SARS-CoV-2-infected individuals (122 in the BA.1/2 wave, 49 in the BA.4/5 wave) were tested for S and N IgG post infection. Sequencing and SARS-CoV-2 variant confirmation were performed on nasal swab samples from individuals infected during the BA.1/2 wave. Results: Twenty-seven Omicron sequence confirmed individuals in the BA.1/2 wave and all 49 in the BA.4/5 wave had pre-infection antibody data. Compared to pre-infection levels, post-infection S IgG increased 6.6-fold from 1294 +/- 302 BAU/ml (mean +/- standard error measurement) to 9796 +/- 1252 BAU/ml ( P < 0.001) during the BA.1/2 wave, and 3.6-fold from 1771 +/- 351 BAU/ml to 8224 +/- 943 BAU/ml ( P < 0.001) during the BA.4/5 wave. N IgG increased post infection 19.1-fold from 0.2 +/- 0.1 to 3.7 +/- 0.5 ( P < 0.001) during the BA.1/2 wave and 13.5-fold from 0.22 +/- 0.1 to 3.2 +/- 0.3 ( P < 0.001) during the BA.4/5 wave. Among 159 infection-na & iuml;ve individuals, positive N IgG levels were detected with a sensitivity of 88% in the 87 individuals who were tested between 14 days and 60 days post infection.Conclusions: The large increases in post-infection S IgG along with the N IgG sensitivity that was comparable to previously reported N IgG sensitivity data in unvaccinated individuals after Omicron infection, support the use of Abbott SARS-CoV-2 assays for detecting increased S IgG and seroconversion of N IgG in vaccinated individuals post Omicron infection. Given that 68% of the United States population is fully vaccinated, these results are of current relevance.
引用
收藏
页码:277 / 280
页数:4
相关论文
共 11 条
  • [1] Longitudinal Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid Immunoglobulin G
    Anderson, Mark
    Stec, Michael
    Gosha, Amy
    Mohammad, Taha
    Boler, Michael
    Suarez, Rebeca Tojo
    Behun, Dylan
    Landay, Alan
    Cloherty, Gavin
    Moy, James
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (11) : 1934 - 1942
  • [2] [Anonymous], SARS-CoV-2 Variants | COVID 19
  • [3] Data, disease and diplomacy: GISAID's innovative contribution to global health
    Elbe, Stefan
    Buckland-Merrett, Gemma
    [J]. GLOBAL CHALLENGES, 2017, 1 (01) : 33 - 46
  • [4] Reliability of SARS-CoV-2 serological testing for influencing public health policies: A reappraisal
    Lippi, Giuseppe
    Plebani, Mario
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 108 : 102 - 103
  • [5] Current immunoassays and detection of antibodies elicited by Omicron SARS-CoV-2 infection
    Migueres, Marion
    Chapuy-Regaud, Sabine
    Miedouge, Marcel
    Jamme, Thibaut
    Lougarre, Catherine
    Da Silva, Isabelle
    Pucelle, Melanie
    Staes, Laetitia
    Porcheron, Marion
    Dimeglio, Chloe
    Izopet, Jacques
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (01)
  • [6] Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool
    O'Toole, Aine
    Scher, Emily
    Underwood, Anthony
    Jackson, Ben
    Hill, Verity
    McCrone, John T.
    Colquhoun, Rachel
    Ruis, Chris
    Abu-Dahab, Khalil
    Taylor, Ben
    Yeats, Corin
    du Plessis, Louis
    Maloney, Daniel
    Medd, Nathan
    Attwood, Stephen W.
    Aanensen, David M.
    Holmes, Edward C.
    Pybus, Oliver G.
    Rambaut, Andrew
    [J]. VIRUS EVOLUTION, 2021, 7 (02)
  • [7] SNP and Phylogenetic Characterization of Low Viral Load SARS-CoV-2 Specimens by Target Enrichment
    Orf, Gregory S.
    Forberg, Kenn
    Meyer, Todd V.
    Mowerman, Illya
    Mohaimani, Aurash
    Faron, Matthew L.
    Jennings, Cheryl
    Landay, Alan L.
    Goldstein, D. Yitz
    Fox, Amy S.
    Berg, Michael G.
    Cloherty, Gavin A.
    [J]. FRONTIERS IN VIROLOGY, 2021, 1
  • [8] Rodgers Mary A, 2022, J Clin Virol, V147, P105080, DOI 10.1016/j.jcv.2022.105080
  • [9] Reduced sensitivity of antibody tests after omicron infection
    Roessler, Annika
    Knabl, Ludwig
    Raschbichler, Lisa-Maria
    Peer, Evelyn
    von Laer, Dorothee
    Borena, Wegene
    Kimpel, Janine
    [J]. LANCET MICROBE, 2023, 4 (01): : E10 - E11
  • [10] Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
    Shrestha, Lok Bahadur
    Foster, Charles
    Rawlinson, William
    Tedla, Nicodemus
    Bull, Rowena A.
    [J]. REVIEWS IN MEDICAL VIROLOGY, 2022, 32 (05)